TrialBMC cancer2025

Preliminary experience of lenvatinib, tislelizumab and transcatheter arterial chemoembolization for BCLC stage C hepatocellular carcinoma: a phase II study.

Xiang Nong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.